Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Immuneering Corp Cl A (IMRX)

Immuneering Corp Cl A (IMRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2400 -0.0500 (-3.88%) 04/10/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.2400 unch (unch) 16:00 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.2100
Day High
1.2800
Open 1.2800
Previous Close 1.2900 1.2900
Volume 152,500 152,500
Avg Vol 176,180 176,180
Stochastic %K 12.64% 12.64%
Weighted Alpha -67.68 -67.68
5-Day Change -0.2700 (-17.88%) -0.2700 (-17.88%)
52-Week Range 1.0000 - 3.8300 1.0000 - 3.8300
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,294
  • Shares Outstanding, K 35,887
  • Annual Sales, $ 0 K
  • Annual Income, $ -61,040 K
  • EBIT $ -64 M
  • EBITDA $ -64 M
  • 60-Month Beta -0.25
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.94

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.41
  • Number of Estimates 2
  • High Estimate -0.41
  • Low Estimate -0.41
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +16.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1300 +9.73%
on 04/09/25
Period Open: 1.4600
1.9100 -35.08%
on 03/21/25
-0.2200 (-15.07%)
since 03/10/25
3-Month
1.1300 +9.73%
on 04/09/25
Period Open: 2.0700
2.2000 -43.64%
on 01/24/25
-0.8300 (-40.10%)
since 01/10/25
52-Week
1.0000 +24.00%
on 08/16/24
Period Open: 2.0100
3.8300 -67.62%
on 09/16/24
-0.7700 (-38.31%)
since 04/10/24

Most Recent Stories

More News
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference

IMRX : 1.2400 (-3.88%)
Immuneering Corporation Announces Grant of Inducement Award

IMRX : 1.2400 (-3.88%)
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

IMRX : 1.2400 (-3.88%)
Immuneering Names Dr. Igor Matushansky as Chief Medical Officer

IMRX : 1.2400 (-3.88%)
Immuneering Announces Clinical Supply Agreement with Regeneron Pharmaceuticals to Evaluate IMM-1-104 in Combination with Libtayo® (cemiplimab)

IMRX : 1.2400 (-3.88%)
Immuneering to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

IMRX : 1.2400 (-3.88%)
Immuneering Provides Positive Update on Phase 2a Arm Studying IMM-1-104 in Combination with Modified FOLFIRINOX for First-Line Pancreatic Cancer

IMRX : 1.2400 (-3.88%)
Immuneering Announces Positive Data Update from Three Pancreatic Cancer Arms of Ongoing Phase 2a Trial of IMM-1-104; Plans to Expand Trial with Additional Arms

IMRX : 1.2400 (-3.88%)
Top 5 Biotech Stocks That Captured Retail Investor Interest The Most In 2024

Despite their stock price struggles, these companies have captivated retail investors with groundbreaking therapies and promising clinical developments.

CERO : 0.7700 (-8.33%)
NKGN : 0.1297 (+8.08%)
IMRX : 1.2400 (-3.88%)
AZTR : 0.2800 (unch)
PBM : 0.4521 (-5.42%)
How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

/CNW/ -- USA News Group News Commentary – Recent advancements in cancer treatment continue to underscore the transformative potential of innovative therapies...

ONCY : 0.5001 (-3.77%)
RPTX : 0.9000 (-3.23%)
IMRX : 1.2400 (-3.88%)
ONC.TO : 0.70 (-5.41%)
RNXT : 0.7910 (-4.70%)
CRGX : 4.07 (+0.49%)

Business Summary

Immuneering Corporation is a biopharmaceutical company advancing a pipeline of oncology and neuroscience product candidates. The company's product candidate includes IMM-1-104. Immuneering Corporation is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 1.3467
2nd Resistance Point 1.3133
1st Resistance Point 1.2767
Last Price 1.2400
1st Support Level 1.2067
2nd Support Level 1.1733
3rd Support Level 1.1367

See More

52-Week High 3.8300
Fibonacci 61.8% 2.7489
Fibonacci 50% 2.4150
Fibonacci 38.2% 2.0811
Last Price 1.2400
52-Week Low 1.0000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar